Get access

Other pharmacological treatments for motor complications and dyskinesias


  • Cheryl Waters MD, FRCP(C)

    Corresponding author
    1. Division of Movement Disorders, Department of Neurology, Columbia University, New York, New York, USA
    • Division of Movement Disorders, Department of Neurology, Columbia University, 710 West 168th Street, New York, NY 10032-3784
    Search for more papers by this author


Controlling motor complications becomes increasingly difficult with disease progression. The “wearing-off” phenomenon is the most-common motor fluctuation. Wearing-off can be treated by dietary manipulation, shortening the dosing interval, substituting sustained-release levodopa, adding amantadine, or monoamine oxidase type B inhibitors, and other options, including catechol-O-methyltransferase inhibitors and the approved dopamine agonists addressed in another chapter. The rotigotine constant-delivery system is being developed to treat wearing-off symptoms. Istradefylline (KW-6002), an adenosine A2A receptor antagonist, has been studied for wearing-off and the results will be discussed. The onoff fluctuations can be treated with liquid levodopa and the rescue therapy of injectable apomorphine. Patients may also suffer from dyskinesias. Dyskinesias can be treated with small doses of liquefied levodopa–carbidopa, amantadine, and clozapine, an atypical neuroleptic. © 2005 Movement Disorder Society

Get access to the full text of this article